Anchiano Therapeutics Ltd. announced the appointment of Salar Roshan as the Company’s Head of Business Development, effective May 28, 2019. Mr. Roshan will report to the Chief Executive Officer and will focus on driving Anchiano’s strategic initiatives. Mr. Roshan joins Anchiano Therapeutics from Curis Inc., an anti-cancer biotechnology company, where he served as Head of Corporate Development and was responsible for overseeing all aspects of the company’s corporate and business development strategy.